Acciones Oncologix Tech, Inc. Other OTC
Acciones
OCLG
US68230M2098
Holding Companies
Ventas 2013 | 0,24 0,23 | Ventas 2014 | 3,68 3,44 | Capitalización | 758 mil 708 mil |
---|---|---|---|---|---|
Resultado Neto 2013 | - 0 | Resultado Neto 2014 | -1 M -934 mil | VE / Ventas 2013 | 8.716.069 x |
Deuda neta 2013 | 1,33 M 1,24 M | Deuda neta 2014 | 1,89 M 1,77 M | VE / Ventas 2014 | 721.342 x |
P/E ratio 2013 |
-1,03
x | P/E ratio 2014 |
-0,47
x | Empleados | - |
Rendimiento 2013 * |
-
| Rendimiento 2014 |
-
| Flotante | 99 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/06/21 |
Nikole Jessie
IRO | Public Communications Contact | - | 01/06/15 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/06/21 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+111,71 % | 6546,76 M | |
+98,02 % | 1232,25 M | |
+2,52 % | 986 M | |
+14,96 % | 752 M | |
+2,11 % | 666 M | |
+2,33 % | 620 M | |
-.--% | 600 M | |
+8,61 % | 528 M | |
-.--% | 500 M |